WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New DDDs

List of new DDDs decided at the latest meetings of the WHO International Working Group for Drug Statistics Methodology. Comments or objections to the DDDs should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology within the deadline. If no objections are received, the new DDDs will be considered final and included in the ATC/DDD Index. The year of implementation in the ATC/DDD Index is given in the list.

ATC codeATC level name (INN/generic name)DDDUnit Adm.routeDeadline for objection to temporary DDDs Implementation in ATC/DDD index if no objection is received
J05AX21imidazolyl ethanamide pentandioic acid90mgO01.02.20182019
P01BD51pyrimethamine, combinations75mg 4)P01.02.20182019
J05AX22kagocel60mgO01.02.20182019
A10AE54insulin glargine and lixisenatide401)P01.02.20182019
G03GA10follitropin delta12mcgP01.02.20182019
A07AA10colistin9MUO01.02.20182019
L04AA37baricitinib4mgO01.02.20182019
N05AX15cariprazine3mgO01.02.20182019
A07AA08kanamycin3gO01.02.20182019
P01AB07secnidazole2gO01.02.20182019
J01DD63ceftriaxone and beta-lactamase inhibitor22)P01.02.20182019
C01CA27droxidopa 1gO01.02.20182019
V03AE09patiromer calcium16.8gO01.02.20182019
L04AC14sarilumab14.3mgP01.02.20182019
R03DX08reslizumab 7.1mgP01.02.20182019
G04BD13desfesoterodine3.5mgO01.02.20182019
J01DB11cefroxadine2.1gO01.02.20182019
G03CA03estradiol1.53mgTD spray01.02.20182019
J05AX17enisamium iodide1.5gO01.02.20182019
J01FA03midecamycin1.2gO01.02.20182019
J01MA23delafloxacin0.9gO01.02.20182019
J01DI03faropenem0.75gO01.02.20182019
R03DA12mepyramine theophyllinacetate0.6gO01.02.20182019
J01MA23delafloxacin0.6gP01.02.20182019
J01DH06tebipenem pivoxil0.56gO01.02.20182019
J01MA22tosufloxacin0.45gO01.02.20182019
J01MA19garenoxacin0.4gO01.02.20182019
J01MA07lomefloxacin0.4gO01.02.20182019
J01DD18cefteram0.4gO01.02.20182019
J01MA15gemifloxacin0.32gO01.02.20182019
J05AR23atazanavir and ritonavir0.33)O01.02.20182019
J05AC02rimantadine0.2gO01.02.20182019
J04AK06delamanid0.2gO01.02.20182019
G02AD06misoprostol0.2mgO01.02.20182019
A07DA06eluxadoline0.2gO01.02.20182019
A06AH05naldemedine0.2mgO01.02.20182019
J05AX19tilorone0.125 gO01.02.20182019
M09AX07nusinersen0.1mgP01.02.20182019
H03AA05thyroid gland preparations0.1gO01.02.20182019
1) refers to insulin glargine
2) refers to ceftriaxone
3) refers to atazanavir
4) refers to pyrimethamine

Last updated: 2017-11-30